|
Multimodal (n = 77)
|
Morphine (n = 74)
|
P-value
|
---|
Age (Mean ± SD)
|
62 ± 12
|
64 ± 13
|
NS
|
Female (n)
|
16
|
15
|
NS
|
BMI (Mean ± SD)
|
27.4 ± 5.1
|
28.1 ± 4.3
|
NS
|
Risk factors/co-morbidity (n(%))
| | | |
Hypertension
|
48
|
47
|
NS
|
Hypercholest.
|
55
|
58
|
NS
|
Diabetes
|
8
|
16
|
0.06(NS)
|
Peripheral arterial disease
|
8
|
6
|
NS
|
Previous TCI/stroke
|
7
|
6
|
NS
|
Severe COPD
|
5
|
4
|
NS
|
Alcohol (Median (min-max))
|
7[0-42]
|
6[0-42]
|
NS
|
Cardiac history (n)
| | | |
MI past (>months)
|
14
|
14
|
NS
|
MI present (<3 months)
|
5
|
4
|
NS
|
CCS
|
2 ± 1
|
2 ± 1
|
NS
|
NYHA class
|
2 ± 1
|
2 ± 1
|
NS
|
Atrial fibrillation
|
5
|
9
|
NS
|
LVEF > 50%
|
33
|
35
|
NS
|
LVEF 30%-50%
|
36
|
26
|
NS
|
LVEF <30%
|
8
|
13
|
NS
|
Euroscore (Mean ± SD
|
5.0 ± 2.9
|
5.2 ± 3.4
|
NS
|
Creatinine (μmol/J)
|
82.6 ± 17.0
|
82.7 ± 15.1
|
NS
|
- BMI = body mass index, TCI = transitory cerebral ischemia, COPD = chronic obstructive pulmonary disease, MI = myocardial infarction, CCS = canadian cardiovascular society, NYHA = New york heart association, LVEF = left ventricular ejection fraction, NS = non-significant.